Biofire Diagnostics, LLC

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$663Kgeneral payments (2019-2025)
$1.0Mresearch payments (2019-2025)
808clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $302K
2020 $119K
2021 $135K
2022 $1,460
2023 $93K
2024 $2,595
2025 $10K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Infectious Disease $169K
Pulmonary Disease $113K
Emergency Medicine $89K
Pediatric Infectious Diseases $72K
Pediatrics $32K
General Practice $29K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Tufik Assad Boston, MA Pulmonary Disease $89,835.89
Jaime Fergie Corpus Christi, TX Pediatric Infectious Diseases $34,252.33
Javeed Siddiqui Roseville, CA Infectious Disease $30,458.90
Rodrigo Hasbun Houston, TX Infectious Disease $30,239.05
Glenn Harnett Hoover, AL General Practice $26,975.29
Kristen Assad Nashville, TN $24,804.08
Ferric Fang Seattle, WA Infectious Disease $23,566.49
Sameer Desai Lexington, KY Emergency Medicine $23,173.15
Andrew Meltzer Washington, DC Emergency Medicine $16,781.20
Daniel Bruckner Encino, CA Pediatrics $14,719.18

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.